Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) Est; Narrows FY2026 Sales Guidance from $2.362B-$2.447B to $2.395B-$2.441B vs $2.406B Est

뉴스 본문을 불러오고 있어요.

Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) Est; Narrows FY2026 Sales Guidance from $2.362B-$2.447B to $2.395B-$2.441B vs $2.406B Est | 웨이프 WAPE

Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) Est; Narrows FY2026 Sales Guidance from $2.362B-$2.447B to $2.395B-$2.441B vs $2.406B Est

기사 요약

관련 종목

댓글 —